Clinical and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial
(2014)
Journal Article
Wiles, N., Thomas, L., Abel, A., Barnes, M., Carroll, F., Ridgway, N., …Lewis, G. (2014). Clinical and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial. Health Technology Assessment, 18(31), 1-167. https://doi.org/10.3310/hta18310
Background: Only one-third of patients with depression respond fully to treatment with antidepressant medication. However, there is little robust evidence to guide the management of those whose symptoms are 'treatment resistant'. Objective: The CoBal... Read More about Clinical and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial.